文献速递炎症性肠病

高压氧治疗20例克罗恩病肛周瘘管

Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease.
PubMed 文献 · Aliment Pharmacol Ther · 2020-12-16

本研究在阿姆斯特丹UMC纳入20例难治性肛周瘘管克罗恩病患者,给予40次高压氧治疗,第16周评估。肛周疾病活动指数和改良van Assche指数均显著下降,65%患者达到非活动状态,60%临床应答、20%临床缓解,CRP和粪钙卫蛋白也显著降低。

要点

  • 高压氧可显著改善难治性肛周瘘管克罗恩病的临床和影像学指标
  • 第16周65%患者肛周疾病活动指数≤4,60%临床应答、20%临床缓解
  • CRP和粪钙卫蛋白在高压氧治疗后显著下降

核心结论

  • 高压氧治疗使难治性肛周瘘管克罗恩病患者获得显著的临床、影像学和生化改善。

研究设计与样本

  • 前瞻性研究,在阿姆斯特丹UMC肛瘘门诊连续纳入20例传统治疗超过6个月失败的高位肛周瘘管克罗恩病患者。
  • 排除标准包括存在造口、直肠阴道瘘和近期治疗方案改变者。
  • 患者接受40次高压氧治疗,第16周评估结局参数。

主要发现

  • 肛周疾病活动指数中位数从7.5(95%CI 6-9)降至4(95%CI 3-6),P<0.001。
  • 改良van Assche指数中位数从9.2(95%CI 7.3-11.2)降至7.3(95%CI 6.9-9.7),P=0.004。
  • 13/20例(65%)患者肛周疾病活动指数≤4,代表肛周疾病非活动。
  • CRP中位数从4.2 mg/mL(95%CI 1.6-8)降至2.2(95%CI 0.9-4.3),P=0.003;粪钙卫蛋白从399 µg/g(95%CI 52-922)降至31(95%CI 16-245),P=0.001。

临床怎么用

  • 对于传统治疗失败的难治性肛周瘘管克罗恩病患者,高压氧可作为改善临床和生化指标的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Positive effects of hyperbaric oxygen on perianal fistulas in Crohn's disease have been reported. AIM: To assess efficacy, safety and feasibility of hyperbaric oxygen in Crohn's disease patients with therapy-refractory perianal fistulas. METHODS: Twenty consecutive patients were recruited at the out-patient fistula clinic of the Amsterdam UMC. Crohn's disease patients with high perianal fistula(s) failing conventional treatment for over 6 months were included. Exclusion criteria were presence of a stoma, rectovaginal fistula(s) and recent changes in treatment regimens. Patients received treatment with 40 hyperbaric oxygen sessions and outcome parameters were assessed at Week 16. RESULTS: Seven women and 13 men were included (median age 34 years). At Week 16, median scores of perianal disease activity index and modified van Assche index (co-primary outcome parameters) decreased from 7.5 (95% CI 6-9) to 4 (95% CI 3-6, P < 0.001), and from 9.2 (95% CI 7.3-11.2) to 7.3 (95% CI 6.9-9.7, P = 0.004) respectively. Perianal disease activity index scores ≤4 (representing inactive perianal disease) were observed in 13/20 patients (65%). Twelve patients showed a clinical response (60%) and four (20%) clinical remission, assessed with fistula drainage assessment. Median C-reactive protein and faecal calprotectin levels decreased from 4.2 mg/mL (95% CI 1.6-8) to 2.2 (95% CI 0.9-4.3, P = 0.003) and from 399 µg/g (95% CI 52-922) to 31 (95% CI 16-245, P = 0.001), respectively. CONCLUSIONS: We found significant clinical, radiological and biochemical improvement in Crohn's disease patients with therapy-refractory perianal fistulas after treatment with hyperbaric oxygen. CLINICAL TRIAL REGISTRATION: www.trialregister.nl/trial/6489.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Lansdorp CA, Gecse KB, Buskens CJ, et al. Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease. Aliment Pharmacol Ther. 2020. PMID: 33326623. doi:10.1111/apt.16228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。